Bladder malignant neoplasms mortality in the U.S. has remained relatively stable, with a slight decrease forecasted from 2024 to 2028. In 2023, the mortality rate was at 7.4 per 100,000 men. By 2028, the rate is expected to decrease to 7.2. This reflects a minor year-on-year variation of approximately -1.3% which is stable when analyzed over the forecasted period. The last five-year CAGR remains comparably low, indicating consistency in mortality rates.
Future trends to watch include advancements in bladder cancer treatment and early detection, which could further reduce mortality rates. Additionally, lifestyle factors and healthcare policy improvements are crucial in impacting long-term trends.
